Physician

Jared Evan Knickelbein, MD/PHD

According to 2025 Medicare claims, Jared Knickelbein, MD/PHD (NPI: 1528357043) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS INC. (NPI: 1063444123; TIN: 251492985) and primary practice location at 15102-1827.

Knickelbein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 610 traditional Medicare patients, billed 45,081 HCPCS/CPT codes, and received $2,133,184 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 750 prescription claims across 200 beneficiaries totaling $29,232 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $381,887 to $2,133,184. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2016 Medicare payment: $381,887 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,134,513 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,483,724 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,657,874 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,580,124 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,771,913 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,643,516 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,790,384 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,133,184 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20164362,359$381,887
20176606,140$1,134,513
20186576,618$1,483,724
20195396,541$1,657,874
20205316,017$1,580,124
20215536,587$1,771,913
20225276,590$1,643,516
202351418,526$1,790,384
202461045,081$2,133,184

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$93K2016 Drug cost: $16,534 (USD; Tot_Drug_Cst)2017 Drug cost: $74,996 (USD; Tot_Drug_Cst)2018 Drug cost: $92,547 (USD; Tot_Drug_Cst)2019 Drug cost: $48,325 (USD; Tot_Drug_Cst)2020 Drug cost: $46,145 (USD; Tot_Drug_Cst)2021 Drug cost: $40,757 (USD; Tot_Drug_Cst)2022 Drug cost: $48,090 (USD; Tot_Drug_Cst)2023 Drug cost: $46,806 (USD; Tot_Drug_Cst)2024 Drug cost: $29,232 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201661141$16,534
2017162610$74,996
2018179691$92,547
2019173754$48,325
2020173767$46,145
2021164631$40,757
2022176723$48,090
2023165731$46,806
2024200750$29,232

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1501,044$657
67028Injection of drug into eye3761,208$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more430820$67
92134Imaging of retina5281,223$30
J2777Injection, faricimab-svoa, 0.1 mg17139,360$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1809,145$8,352
DifluprednateDifluprednate621,974$7,579
Brimonidine TartrateBrimonidine Tartrate673,226$3,000
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1017,414$2,238
Atropine SulfateAtropine Sulfate321,649$1,332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$16Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jared Evan Knickelbein, MD/PHD?

Tedicare shows public-source Medicare data for Jared Evan Knickelbein, MD/PHD (NPI 1528357043), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jared Evan Knickelbein, MD/PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jared Evan Knickelbein, MD/PHD?

Jared Evan Knickelbein, MD/PHD is linked to RETINA VITREOUS CONSULTANTS INC. (billing NPI 1063444123) in the available physician profile data.

Does Jared Evan Knickelbein, MD/PHD have Open Payments data?

Jared Evan Knickelbein, MD/PHD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.